tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Paul Knight, 26 are a HOLD (12.56%), 180 are a BUY (86.96%), 1 are a SELL (0.48%).
Analyst Paul Knight, currently employed at KEYBANK, carries an average stock price target met ratio of 53.19% that have a potential upside of 40.97% achieved within 227 days.
Paul Knight’s has documented 389 price targets and ratings displayed on 35 stocks. The coverage is on Healthcare, Basic Materials, Technology, Industrials, Consumer Cyclical sectors.
Most recent stock forecast was given on RVTY, Revvity at 04-Sep-2026.
Analyst best performing recommendations are on OCX (ONCOCYTE CORP).
The best stock recommendation documented was for CYRX (CRYOPORT) at 1/19/2021. The price target of $75 was fulfilled within 3 days with a profit of $10.82 (16.86%) receiving and performance score of 56.2.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 26-Feb-2026
$195
$24.46 (14.34%)
$150
Buy Since 25-Nov-2025
$185
$14.46 (8.48%)
$155
1 months 13 days ago
(27-Aug-2026)
28/31 (90.32%)
$27.31 (17.32%)
400
Buy Since 27-Feb-2026
$175
$4.46 (2.62%)
$150
1 months 13 days ago
(27-Aug-2026)
2/2 (100%)
$17.31 (10.98%)
103
Buy Since 02-Jun-2026
$180
$9.46 (5.55%)
$155
1 months 13 days ago
(27-Aug-2026)
4/5 (80%)
$22.31 (14.15%)
109
Buy Since 09-Oct-2025
$190
$19.46 (11.41%)
$180
1 months 13 days ago
(27-Aug-2026)
1/3 (33.33%)
$32.31 (20.49%)
348
Which stock is Paul Knight most bullish on?
Which stock is Paul Knight most reserved on?
What Year was the first public recommendation made by Paul Knight?
